Effect of Rosiglitazone and Ramipril on β-Cell Function in People With Impaired Glucose Tolerance or Impaired Fasting Glucose: The DREAM trial

OBJECTIVE: The objective of this study was to determine the degree to which ramipril and/or rosiglitazone changed β-cell function over time among individuals with impaired fasting glucose (IFG) and/or impaired glucose tolerance (IGT) who participated in the Diabetes Reduction Assessment With Ramipri...

Descripción completa

Detalles Bibliográficos
Autores principales: Hanley, Anthony J., Zinman, Bernard, Sheridan, Patrick, Yusuf, Salim, Gerstein, Hertzel C.
Formato: Texto
Lenguaje:English
Publicado: American Diabetes Association 2010
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2827518/
https://www.ncbi.nlm.nih.gov/pubmed/20009095
http://dx.doi.org/10.2337/dc09-1579

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2827518/
https://www.ncbi.nlm.nih.gov/pubmed/20009095
http://dx.doi.org/10.2337/dc09-1579

Ejemplares similares